Furthermore, combination treatment of R788 and anti-PDL1 mAb leads to complete tumor regression in 50% mice with durable anti-tumor immunity in small NB9464 tumors but not larger NB9464 tumors. The gene discussed is CD274; the disease is neoplasm.